Global Liposomes Drug Delivery Market Study By Segment (Liposomal doxorubicin, Liposomal Amphoteracin B, Liposomal Paclitaxel), By Market (Fungal Infection Therapy, Cancer Therapy ( Tumor therapy)Liposomal Amphoteracin B, Others), By Company (Johnson & Johnson, Gilead Sciences, Luye Pharma) 2015-2025
Report ID: 1366 | Sep 2018 | No. of Pages: 79 |
Snapshot

Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only. In a liposome drug product, the drug substance is contained in liposomes. Typically, water soluble drugs are contained in the aqueous compartment(s) and hydrophobic drugs are contained in the lipid layer(s) of the liposomes. Release of drugs from liposome formulations can be modified by the presence of polyethylene glycol and/or cholesterol or other potential additives in the liposome.
The global Liposomes Drug Delivery market will reach xxx Million USD in 2018 and with a CAGR if xx% between 2019-2025.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Liposomal doxorubicin
Liposomal Amphoteracin B
Liposomal Paclitaxel
Others

Demand Coverage (Market Size & Forecast, Consumer Distribution):
Fungal Infection Therapy
Cancer Therapy ( Tumor therapy)
Others

Company Coverage (Sales data, Main Products & Services etc.):
Johnson & Johnson
Gilead Sciences
Luye Pharma
Sun Pharmaceutical
Pacira
Fudan-Zhangjiang
Sigma-Tau Group
Teva Pharmaceutical
CSPC
Novartis
Crucell
Celsion Corporation
Kingond Pharm
Shanghai New Asia
Spectrum Pharmaceuticals

Major Region Market
North America
Europe
Asia-Pacific
South America
Middle East & Africa
Table of Content
1 Industry Overview
1.1 Liposomes Drug Delivery Industry
1.1.1 Overview
1.1.2 Products of Major Companies
1.2 Market Segment
1.2.1 Industry Chain
1.2.2 Consumer Distribution
1.3 Price & Cost Overview
2 Liposomes Drug Delivery Market by Type
2.1 By Type
2.1.1 Liposomal doxorubicin
2.1.2 Liposomal Amphoteracin B
2.1.3 Liposomal Paclitaxel
2.1.4 Others
2.2 Market Size by Type
2.3 Market Forecast by Type
3 Global Market Demand
3.1 Segment Overview
3.1.1 Fungal Infection Therapy
3.1.2 Cancer Therapy ( Tumor therapy)
3.1.3 Others
3.2 Market Size by Demand
3.3 Market Forecast by Demand
4 Major Region Market
4.1 Global Market Overview
4.1.1 Market Size & Growth
4.1.2 Market Forecast
4.2 Major Region
4.2.1 Market Size & Growth
4.2.2 Market Forecast
5 Major Companies List
5.1 Johnson & Johnson (Company Profile, Sales Data etc.)
5.2 Gilead Sciences (Company Profile, Sales Data etc.)
5.3 Luye Pharma (Company Profile, Sales Data etc.)
5.4 Sun Pharmaceutical (Company Profile, Sales Data etc.)
5.5 Pacira (Company Profile, Sales Data etc.)
5.6 Fudan-Zhangjiang (Company Profile, Sales Data etc.)
5.7 Sigma-Tau Group (Company Profile, Sales Data etc.)
5.8 Teva Pharmaceutical (Company Profile, Sales Data etc.)
5.9 CSPC (Company Profile, Sales Data etc.)
5.10 Novartis (Company Profile, Sales Data etc.)
5.11 Crucell (Company Profile, Sales Data etc.)
5.12 Celsion Corporation (Company Profile, Sales Data etc.)
5.13 Kingond Pharm (Company Profile, Sales Data etc.)
5.14 Shanghai New Asia (Company Profile, Sales Data etc.)
5.15 Spectrum Pharmaceuticals (Company Profile, Sales Data etc.)
6 ConclusionTable Global Liposomes Drug Delivery Market 2015-2018, by Type, in USD Million
Table Global Liposomes Drug Delivery Market 2015-2018, by Type, in Volume
Table Global Liposomes Drug Delivery Market Forecast 2019-2025, by Type, in USD Million
Table Global Liposomes Drug Delivery Market Forecast 2019-2025, by Type, in Volume
Table Johnson & Johnson Overview List
Table Liposomes Drug Delivery Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Gilead Sciences Overview List
Table Liposomes Drug Delivery Business Operation of Gilead Sciences (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Luye Pharma Overview List
Table Liposomes Drug Delivery Business Operation of Luye Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sun Pharmaceutical Overview List
Table Liposomes Drug Delivery Business Operation of Sun Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pacira Overview List
Table Liposomes Drug Delivery Business Operation of Pacira (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Fudan-Zhangjiang Overview List
Table Liposomes Drug Delivery Business Operation of Fudan-Zhangjiang (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sigma-Tau Group Overview List
Table Liposomes Drug Delivery Business Operation of Sigma-Tau Group (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Teva Pharmaceutical Overview List
Table Liposomes Drug Delivery Business Operation of Teva Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table CSPC Overview List
Table Liposomes Drug Delivery Business Operation of CSPC (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novartis Overview List
Table Liposomes Drug Delivery Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Crucell Overview List
Table Liposomes Drug Delivery Business Operation of Crucell (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Celsion Corporation Overview List
Table Liposomes Drug Delivery Business Operation of Celsion Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Kingond Pharm Overview List
Table Liposomes Drug Delivery Business Operation of Kingond Pharm (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Shanghai New Asia Overview List
Table Liposomes Drug Delivery Business Operation of Shanghai New Asia (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Spectrum Pharmaceuticals Overview List
Table Liposomes Drug Delivery Business Operation of Spectrum Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)Figure Global Liposomes Drug Delivery Market Growth 2015-2018, by Type, in USD Million
Figure Global Liposomes Drug Delivery Market Growth 2015-2018, by Type, in Volume

Select License Type
USD $1800
USD $3600
USD $3600
Connect With Us

+1-707-633-0404


COVID-19 Impact on Breast Pump Market By Key Manufacturers, By Type (Electric Breast Pump, Manual Breast Pump), By Application (Hospital Use, Household Use) and and By Region (North America, Latin America, Europe, Asia Pacific, Middle East and Africa) - Global Outlook to 2026
Publication Month: May 2020 | No. of Pages: 120
$4250
Buy Now
COVID-19 Impact on Microfluidics Market By Key Manufacturers, By Type (Polymer-Based Microfluidics, Glass-Based Microfluidics, Silicon-Based Microfluidics, Other Materials-Based (Paper & Ceramics) Microfluidics), By Application (Pharmaceutical Research, In Vitro Diagnostics, Drug Delivery) and and By Region (North America, Latin America, Europe, Asia Pacific, Middle East and Africa) - Global Outlook to 2026
Publication Month: May 2020 | No. of Pages: 120
$4250
Buy Now
COVID-19 Impact on Surgical Stapling Device Market By Key Manufacturers, By Type (Straight Surgical Stapling Devices, Curved Surgical Stapling Devices, Circular Surgical Stapling Devices, Others), By Application (Gastrointestinal Surgery, Gynecologic Surgery, Thoracic Surgery, Others) and and By Region (North America, Latin America, Europe, Asia Pacific, Middle East and Africa) - Global Outlook to 2026
Publication Month: May 2020 | No. of Pages: 120
$4250
Buy Now
COVID-19 Impact on Handheld Ultrasound Scanner Market By Key Manufacturers, By Type (Wired Scanners, Wireless Scanners), By Application (Hospitals, Diagnostic Centers, Ambulatory Surgical Centers) and and By Region (North America, Latin America, Europe, Asia Pacific, Middle East and Africa) - Global Outlook to 2026
Publication Month: May 2020 | No. of Pages: 120
$4250
Buy Now
COVID-19 Impact on Endoscope Reprocessing Device Market By Key Manufacturers, By Type (Single Basin Automated Endoscope Reprocessors, Double Basin Automated Endoscope Reprocessors), By Application (Hospitals, Ambulatory Surgical Centers, Clinics) and and By Region (North America, Latin America, Europe, Asia Pacific, Middle East and Africa) - Global Outlook to 2026
Publication Month: May 2020 | No. of Pages: 120
$4250
Buy Now